Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Not Applicable
1 (33.3%)Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified
Phase 1
Completed
- Conditions
- Bipolar Disorder
- Interventions
- First Posted Date
- 2012-01-11
- Last Posted Date
- 2016-03-08
- Lead Sponsor
- L. Eugene Arnold
- Target Recruit Count
- 23
- Registration Number
- NCT01507753
- Locations
- 🇺🇸
Ohio State University Medical Center- Harding Hospital, Columbus, Ohio, United States
Omega-3 and Therapy Study for Depression
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2011-04-26
- Last Posted Date
- 2016-03-08
- Lead Sponsor
- L. Eugene Arnold
- Target Recruit Count
- 73
- Registration Number
- NCT01341925
- Locations
- 🇺🇸
Ohio State University Medical Center - Harding Hospital, Columbus, Ohio, United States
Pilot Feasibility Study of Neurofeedback for Attention Deficit Hyperactivity Disorder (ADHD)
Not Applicable
Completed
- Conditions
- Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2016-11-11
- Lead Sponsor
- L. Eugene Arnold
- Target Recruit Count
- 39
- Registration Number
- NCT00886483
- Locations
- 🇺🇸
The Ohio State University Nisonger Center, Columbus, Ohio, United States
News
No news found